In vivo kinetics of [18F](N-methyl)benperidol: A novel PET tracer for assessment of dopaminergic D2-like receptor binding

Journal of Cerebral Blood Flow and Metabolism

Volumn 17, Issue 8, 1997, Pages 833-845

  Moerlein, Stephen M ^a,b   Perlmutter, Joel S ^a,b   Markham, Joanne ^b   Welch, Michael J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Benperidol; Dopaminergic D2 receptors; Imaging; Neuroreceptors; Positron emission tomography; 18F (N methyl)benperidol

Indexed keywords

BENPERIDOL; DOPAMINE 2 RECEPTOR; FLUORINE 18; DRUG DERIVATIVE; N METHYLBENPERIDOL; N-METHYLBENPERIDOL;

ANIMAL TISSUE; ARTICLE; BABOON; BRAIN SCINTISCANNING; CEREBELLUM; CORPUS STRIATUM; ISOTOPE LABELING; LIGAND BINDING; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR DENSITY; ANIMAL; BRAIN; COMPUTER ASSISTED EMISSION TOMOGRAPHY; METABOLISM; PAPIO;

ANIMALS; BENPERIDOL; BRAIN; PAPIO; RECEPTORS, DOPAMINE D2; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0030611928     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004647-199708000-00002     Document Type: Article

References (81)

1. 18F-labeled butyrophenone neuroleptic drugs in the baboon using positron emission tomography. J Neurochem 44:835-844
2. 18F]-N-methylspiroperidol and PET. J Nucl Med 27:1878-1882
3. Baron JC, Comar D, Farde L, Martinot JL, Mazoyer B, eds (1991) Brain Dopaminergic Systems: Imaging with Positron Emission Tomography, Boston: Kluwer Academic Publishers, Boston Academic Publishers
4. 11C-raclopride and positron emission tomography. Ann Neurol 31:184-192
5. Burt DR, Creese I, Snyder SH (1977) Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain. Science 196:326-328
6. 3H]spiperone binding: evidence for accumulation in corpus striatum by agonist-mediated receptor internalization. J Cereb Blood Flow Metab 8:291-303
7. 18F]fluoro-ethyl)spiperone in baboon brain. Eur J Nucl Med 14:80-87
8. Creese I, Burt DR, Snyder SH (1976) Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science 192:481-483
9. Davis R, Huffman RD (1968) A Stereotaxic Atlas of the Brain of the Baboon, Austin, TX: University of Texas Press
10. 11C-raclopride and positron emission tomography. J Neurosci 12:3773-3780
11. 11C-raclopride is altered by drugs that modify synaptic dopamine level. Synapse 13:350-356
12. 11C]raclopride. Psychopharmacology 107:23-29
13. Farde L, Erling E, Eriksson L, Greitz T, Hall H, Hedström C-G, Litton J-E, Sedvall G (1985) Substituted benzamides as ligands for visualization of dopamine receptor binding in the human brain by positron emission tomography. Proc Natl Acad Sci USA 82:3863-3867
14. Farde L, Weisel F-A, Jansson P, Uppfeldt G, Wahlen A, Sedvall G (1988) An open label trial of raclopride in acute schizophrenia. Confirmation of D2-dopamine receptor occupancy by PET. Psychopharmacology 94:1-7
15. 2-dopamine receptor binding examined in vivo by PET. Acta Scand 82 (Suppl 358):67-71
16. 2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Arch Gen Psychiatry 49:538-544
17. Fox PT, Perlmutter JS, Raichle ME (1985) A stereotactic method of anatomical localization for positron emission tomography. J Comput Assist Tomogr 9:141-153
18. 3H-N-methylspiperone to dopamine and serotonin receptors. Life Sci 40:987-995
19. Frost JJ, Wagner HN, Jr (eds) (1990) Quantitative Imaging. Neuroreceptors, Neurotransmitters, and Enzymes, New York: Raven Press
20. 2 dopamine receptors in caudate nucleus. Neurosurg Rev 10:9-17
21. 11C-N-methyl-spiperone. Acta Neurol Scand 75:87-94
22. 2 receptors in the rat brain. Eur J Pharmacol 111:191-199
23. 3H-raclopride. J Neural Transm 73:7-21
24. 2 dopamine receptor occupancy of risperidone and its relationship to extrapyramidal symptoms: a PET study. Life Sci 57:PL 103-107
25. 18F]fluoropropylepidipride as a potential PET radioligand for imaging dopamine D2 receptors. Synapse 15: 169-176
26. 3H]raclopride. Neurosci Lett 66:85-90
27. Lee T, Seeman P, Rajput A, Farley I, Hornykiewicz O (1978a) Receptor basis for dopaminergic supersensitivity in Parkinson's disease. Nature 273:59-60
28. 3H-apomorphine in schizophrenic brains. Nature 274:897-900
29. Lee T, Seeman P (1980) Elevation of brain neuroleptic/dopamine receptors in schizophrenia. Am J Psychiatry 137:191-197
30. 2 receptor occupancy in human volunteers measured using positron emission tomogrpahy (PET). Eur J Clin Pharmacol 44:135-140
31. 18F]fluoropropylbenzamides for dopamine D-2 receptor studies. Nucl Med Biol 19:571-588
32. Mazoyer B, Trebossen R, Deutch R, Casey M, Blohm K (1991) Physical Characteristics of the ECAT 953B/31: A new high resolution brain positron tomograph. IEEE Trans Med Imaging 10:499-504
33. Mintum MA, Raichle ME, Kilbourn MR, Wooten GF, Welch MJ (1984) A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography. Ann Neurol 15: 217-227
34. 75Br-labelled butyrophenone neuroleptics for imaging cerebral dopaminergic receptor areas using positron emission tomography. Eur J Nucl Med 12:211-216
35. Moerlein SM, Banks WR, Parkinson D (1992a) Production of fluorine-18 labeled (3-N-methyl)benperidol for PET investigation of cerebral dopaminergic receptor binding. Appl Rad Isot 43:97-100
36. 2 receptors demonstrated in vivo by PET. Neurosci Lett 148:97-100
37. 18F-labeled ligand. Nucl Med Biol 22:809-815
38. 18F](N-methyl)benperidol as determined by whole-body PET imaging of primates. Nucl Med Biol 24:311-318
39. Moghaddam B, Berridge CW, Goldman-Rakic PS, Bunney BS, Roth RH (1993) In vivo assessment of basal and drug-induced dopamine release in cortical and subcortical regions of the anesthetized primate. Synapse 13:215-222
40. Nordström A-L, Farde L, Wiesel F-A, Forslund K, Pauli S, Halldin C, Uppfeldt G (1993) Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: a double-blind PET study of schizophrenic patients. Biol Psychiatry 33:227-235
41. Owen F, Cross AJ, Crow TJ, Longden A, Poulter M, Riley GJ (1978) Increased dopamine receptor sensitivity in schizophrenia. Lancet 2:223-225
42. Patlak CS, Blasberg RG, Fenstermacher JD (1983) Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab 3:8-32
43. Patlak CS, Blasberg RG (1985) Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data: generalizations. J Cereb Blood Flow Metab 5:584-590
44. Perlmutter JS, Larson KB, Raichle ME, Markham J, Mintun MA, Kilbourn MR, Welch MJ (1986) Strategies for in vivo measurement of receptor binding using positron emission tomography. J Cereb Blood Flow Metab 6:154-169
45. Perlmutter JS, Kilbourn MR, Raichle ME, Welch MJ (1987) MPTP Induced up-regulation of in vivo dopaminergic radioligand-receptor binding in man. Neurology 37:1575-1579
46. Perlmutter JS, Kilbourn MR, Welch MJ, Raichle ME (1989) Non-steady-state measurement of in vivo receptor binding with positron emission tomography: 'dose-response' analysis. J Neurosci 9: 2344-2352
47. Perlmutter JS, Lieh LL, Margenau W, Buchholz S (1991a) PET measured evoked cerebral blood flow responses in an awake monkey. J Cereb Blood Flow Metab 11:229-235
48. Perlmutter JS, Moerlein SM, Hwang DR, Todd RD (1991b) Non-steady-state measurement of in vivo radioligand binding with positron emission tomography: specificity analysis and comparison with in vitro binding. J Neurosci 11:1381-1389
49. 18F]spiperone binding in putamen in idiopathic focal dystonia. J Neurosci 17:834-842
50. Peroutka SJ, Snyder SH (1980) Relationship of neuroleptic drug effects at brain dopamine, serotonin, α-adrenergic and histamine receptors to clinical potency. Am J Psychiatry 137:1518-1522
51. Protais P, Chagraoui A, Arbaoui J, Mocaer E (1994) Dopamine receptor antagonist properties of S 14506, 8-OH-DPAT, raclopride and clozapine in rodents. Eur J Pharmacol 271:167-177
52. Reisine TD, Fields JZ, Yamamura HI, Bird ED, Spokes E, Schreiner PS, Enna SJ (1977a) Neurotransmitter receptor alterations in Parkinson's disease. Life Sci 21:335-344
53. Reisine TD, Fields JZ, Stern LZ, Johnson PC, Bird ED, Yamamura, HI (1977b) Alterations in dopaminergic receptors in Huntington's disease. Life Sci 21:1123-1128
54. Reynolds JEF (ed) (1993) Martindale The Extra Pharmacopeia, ed 30, London: The Pharmaceutical Press
55. 2 receptor supersensitivity in the striatum of patients with early Parkinson's disease. Mov Disord 5:55-59
56. 2 receptor changes during the progression of early Parkinson's disease. Mov Disord 8:134-138
57. 2 receptor status. Brain 116:853-867
58. Schotte A, Janssen PFM, Megens AAHP, Leysen JE (1993) Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography. Brain Res 631:191-202
59. 1 receptor binding in the monkey using PET. Psychopharmacology 103:150-153
60. Seeman P, Lee T, Chau-Wong M, Wong K (1976) Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature 261:717-719
61. 3H]raclopride: implications for positron emission tomography of the human brain. Synapse 3:96-97
62. 4. Neuropsychopharmacology 7:261-284
63. Soudijn W, van Wijngaarden I, Allewijn F (1967) Distribution, excretion and metabolism of neuroleptics of the butyrophenone type. Eur J Pharmacol 1:47-57
64. Spinks TJ, Jones T, Gilardi MC, Heather JD (1988) Physical performance of the latest generation of commercial positron scanner. IEEE Trans Nucl Sci 35:721-725
65. Spinks TJ, Jones T, Bailey DL, Townsend DW, Grootoonk S, Bloomfield PM, Gilardi M-C, Casey ME, Sipe B, Reed J (1993): Physical performance of positron tomograph for brain imaging with retractable septa. Phys Med Biol 37:1637-1655
66. 2 receptors. J Pharmacol Exp Ther 226:1374-1384
67. Strange PG (1993) Dopamine receptors in the basal ganglia: relevance to Parkinson's disease. Mov Disord 8:263-270
68. 11C-methyl-benperidol. J Nucl Med 31:2015-2021
69. Ter-Pogossian MM, Ficke DC, Hood JT, Yamamoto M, Mullani N (1982) PET VI: a positron tomograph utilizing cesium fluoride scintillation detectors. J Comp Assist Tomogr 6:125-133
70. Todd RD, Carl J, Harmon S, O'Malley KL, Perlmutter J (1996) Dynamic changes in striatal dopamine D2 and D3 receptor protein and mRNA in response to MPTP denervation in baboons. J Neurosci 16:7776-7782
71. Videen TO, Perlmutter JS, Herscovitch P, Raichle ME (1987) Brain blood volume, flow and oxygen utilization measured with O-15 tracers and positron emission tomography: revised metabolic computations. J Cereb Blood Flow Metab 7:513-516
72. 11C]raclopride in the human brain. Synapse 16:255-262
73. Wagner HN Jr, Burns HD, Dannals RF, Wong DF, Lanstrom B, Duelfer T, Frost JJ, Ravert HT, Links JM, Rosenbloom SB, Lukas SE, Kramer AV, Kuhar MJ (1983) Imaging dopamine receptors in the human brain by positron tomography. Science 221:1264-1266
74. Wagner HN Jr, Burns HD, Dannals RF, Wong DF, Langström, Duelfer T, Frost JJ, Ravert HT, Links JM, Rosenbloom SB, Lukas SE, Kramer AV, Kuhar MJ (1984) Assessment of dopamine receptor densities in the human brain with carbon-11-labeled N-methylspiperone. Ann Neurol 15 (Suppl) S79-S84
75. Welch MJ, Kilbourn MR (1985) A remote system for the routine production of oxygen-15 radiopharmaceuticals. J Lab Comp Radiopharm 22:1193-1200
76. 18F]fluoroethylspiperone: findings in disorders related to the dopaminergic system. J Neural Transm Gen Sect 81:195-213
77. Wong DF, Wagner HF Jr, Dannals RF, Links JM, Frost JJ, Ravert HT, Wilson AA, Rosenbaum AE, Gjedde A, Douglass KH, Petronis JD, Folstein MF, Toung JKT, Burns HD, Kuhar MJ (1984) Effects of age on dopamine and serotonin receptors measured by positron emission tomography in the living human brain. Science 226: 1393-1396
78. 2 dopamine receptors in drug-naive schizophrenics. Science 234: 1558-1563
79. 11C]-methyl)-2-Br-LSD. Synapse 1:6 393-398
80. Woods RP, Cherry SR, Mazziotta JC (1993) Rapid automated algorithm for aligning and reslicing PET images. J Comput Assist Tomogr 17:536-546
81. Yamamoto M, Ficke DC, Ter-Pogossian MM (1982) Performance study of PETT VI, a positron emission tomograph with 288 cesium fluoride detectors. IEEE Trans Nucl Sci 29:529-533